5th Joint triennial congress of the European and Americas Committees
for Treatment and Research in Multiple Sclerosis
Amsterdam, The Netherlands
19.10.2011 - 22.10.2011
Please select a day:
19.10.2011
20.10.2011
21.10.2011
22.10.2011
Search

Personal programme
Please enter your email address here in order to bring up your personal programme




Home


Thursday, October 20, 2011

- Click on a checkbox to select a whole session.
- Session titles which are underlined can be clicked upon to show further details.
- Individual programme items can also be selected.
- Go to another day to select further points or click on display to show your saved personal programme.
08:30 ECTRIMS / ACTRIMS Opening Session
Welcome and ECTRIMS Lecture (Plenary Session 1)
10:30 How to decide whether a patient responds to treatment (Parallel Session 1)
10:30 Cellular infiltration into the brain: new ways for immunomodulation in MS (Parallel Session 2)
10:30 OCT in MS (Parallel Session 3)
12:45 Biogen Idec
Addressing MS patient needs today and tomorrow (Satellite Symposium)
14:00 Functional reorganisation and rehabilitation (Parallel Session 4)
14:00 New biomarkers for MS (Parallel Session 5)
14:00 Paediatric MS (Parallel Session 6)
15:30 Poster Viewing Session I:
15:30 Diagnosis & differential diagnosis 1 (Poster topic 1)
15:30 MS variants 1 (Poster topic 2)
15:30 Paediatric MS 1 (Poster topic 3)
15:30 Natural course 1 (Poster topic 4)
15:30 Epidemiology 1 (Poster topic 5)
15:30 MS symptoms 1 (Poster topic 6)
15:30 Clinical assessment tools 1 (Poster topic 7)
15:30 Economic burden (Poster topic 8)
15:30 Pathology 1 (Poster topic 9)
15:30 Grey matter damage in MS 1 (Poster topic 10)
15:30 Experimental models 1 (Poster topic 11)
15:30 Genetics/transcriptomics 1 (Poster topic 12)
15:30 Immunology 1 (Poster topic 13)
15:30 MS and infections 1 (Poster topic 14)
15:30 Environmental risk factors 1 (Poster topic 15)
15:30 Neurobiology 1 (Poster topic 16)
15:30 Repairing mechanisms 1 (Poster topic 17)
15:30 Imaging 1 (Poster topic 18)
15:30 Neurophysiology 1 (Poster topic 19)
15:30 Neuropsychology and fatigue 1 (Poster topic 20)
15:30 Immunomodulation 1 (Poster topic 21)
15:30 Immunosuppression 1 (Poster topic 22)
15:30 Neuroprotection 1 (Poster topic 23)
15:30 Long-term treatment monitoring 1 (Poster topic 24)
15:30 Risk management for disease-modifying treatments 1 (Poster topic 25)
15:30 Tools for detecting therapeutic response 1 (Poster topic 26)
15:30 Others 1 (Poster topic 27)
15:30 Treatment of specific symptoms 1 (Poster topic 28)
15:30 Comprehensive care & rehabilitation 1 (Poster topic 29)
15:30 Quality of life 1 (Poster topic 30)
15:30 Neuro-Ophthalmology 1 (Poster topic 31)
15:30 Biomarkers 1 (Poster topic 32)
15:30 Chronic cerebro-spinal venous insufficiency (CCSVI) 1 (Poster topic 33)
17:00 Diagnostic criteria for MS (Hot Topic 1)
17:00 Mitochondria in MS (Hot Topic 2)
17:00 High field MRI in MS (Hot Topic 3)
18:00 Merck Serono S.A.
MS: It’s a marathon, not a sprint. Optimizing patient outcomes throughout the MS journey (Satellite Symposium)
19:15 Bayer HealthCare Pharmaceuticals
Early treatment and beyond: making meaningful connections (Satellite Symposium)